Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.45 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16141474 | 0.77 | AKR1C3 (0.44) | KDM4EALDH1A1 | |
| SCHEMBL29899029 | 0.76 | MAPT (0.55) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL26932950 | 0.76 | RAB9A (0.40) | KDM4EALDH1A1LMNAKMT2A | |
| SCHEMBL26932629 | 0.76 | RAB9A (0.40) | KDM4EALDH1A1LMNAKMT2A | |
| SCHEMBL995610 | 0.75 | EGFR (0.71) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL995609 | 0.75 | EGFR (0.71) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL1792662 | 0.75 | EGFR (0.71) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL10906195 | 0.74 | RAB9A (0.55) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL21726046 | 0.73 | RAB9A (0.38) | KDM4EALDH1A1LMNAKMT2A | |
| SCHEMBL20240051 | 0.72 | EGFR (0.57) | EGFRKDM4ECISD1SLC16A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10562913-B2 | Indolizine-based dyes for dye-sensitized solar cell | UNIVERSITY OF MISSISSIPPI (US) | 2020-02-18 | — | — | US | disclosed |
| EP-2776515-B1 | ORGANIC COLOURANT AND USES THEREOF IN PHOTOVOLTAIC CELLS | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2019-08-28 | — | — | EP | disclosed |
| US-20170226125-A1 | INDOLIZINE-BASED DYES FOR DYE-SENSITIZED SOLAR CELL | UNIVERSITY OF MISSISSIPPI | 2017-08-10 | — | — | US | disclosed |
| US-20170226125-A1 | INDOLIZINE-BASED DYES FOR DYE-SENSITIZED SOLAR CELL | UNIVERSITY OF MISSISSIPPI | 2017-08-10 | — | — | US | disclosed |
| US-9171676-B2 | Organic colourant and uses thereof in photovoltaic cells | COMMISSARIAT {dot over (A)} L'ĖNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (FR) | 2015-10-27 | — | — | US | disclosed |
| US-20140290748-A1 | ORGANIC COLOURANT AND USES THEREOF IN PHOTOVOLTAIC CELLS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2014-10-02 | — | — | US | disclosed |
| WO-2013068588-A1 | ORGANIC COLOURANT AND USES THEREOF IN PHOTOVOLTAIC CELLS | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2013-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226125-A1 | INDOLIZINE-BASED DYES FOR DYE-SENSITIZED SOLAR CELL | INMT, IDO1, IDO2 | EGFR 3381/4885KDM4E 1805/4885CISD1 217/4885 |
| US-10562913-B2 | Indolizine-based dyes for dye-sensitized solar cell | INMT, IDO1, IDO2 | EGFR 3381/4885KDM4E 1805/4885CISD1 217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.